Episode 86
This episode focuses on machine learning and how it may help diagnose metabolic dysfunction-associated steatotic liver disease (MASLD). Host Aaron Lohr talks with Christos S. Mantzoros, MD, PhD, professor of medicine at Harvard Medical School and the editor-in-chief of the journal Metabolism. Dr. Mantzoros and his team presented their work at ENDO 2024 in Boston, and their abstract was title, “Accurate machine-learning-based diagnosis of at-risk MASH and MASLD subtypes using categorical, radiant boosting, and select clinical, biochemical, and metabolomic measurements: Building highly robust models with few variables through a multi-national, multi-center, biopsy-proven cohort.”
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
We empower high-quality, equitable healthcare for people with hormone health conditions, including diabetes and obesity, infertility, thyroid conditions, osteoporosis, and hormone-related cancers. Together, we promote an environment that helps people of all backgrounds and ethnicities access the medical care they need.
